Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/14
End: 11/30/20
Due: 11/30/21
Phase: N/A
Priority: Normal
Start: 10/31/16
End: 06/30/22
Due: 06/30/23
Safety and Efficacy Study of the Amaranth Medical APTITUDE Bioresorbable Drug-Eluting Coronary Stent
Phase: N/A
Priority: Normal
Start: 11/30/15
End: 07/31/21
Due: 07/31/22
Phase: N/A
Priority: Normal
Start: 02/28/15
End: 11/30/20
Due: 11/30/21
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Feasibility Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent | NCT02189499 | Amaranth Medical Inc. | user2@example.com | None | 2014-09-30 | 2020-11-30 | 2021-11-30 | - | - | 2025-07-14 |
| Safety and Efficacy Study of the Amaranth Medical MAGNITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT III) | NCT02900937 | Amaranth Medical Inc. | user2@example.com | None | 2016-10-31 | 2022-06-30 | 2023-06-30 | - | - | 2025-07-14 |
| Safety and Efficacy Study of the Amaranth Medical APTITUDE Bioresorbable Drug-Eluting Coronary Stent | NCT02568462 | Amaranth Medical Inc. | user2@example.com | None | 2015-11-30 | 2021-07-31 | 2022-07-31 | - | - | 2025-07-14 |
| Safety and Efficacy Study of the Amaranth Medical FORTITUDE Bioresorbable Drug-Eluting Coronary Stent | NCT02255864 | Amaranth Medical Inc. | user2@example.com | None | 2015-02-28 | 2020-11-30 | 2021-11-30 | - | - | 2025-07-14 |